DOT1L and Myocardial fibrosis: In this study, we demonstrated that Dot1L could be a novel myofibroblasts activator, which upregulation in a mouse model of MI is an accomplice in myocardial fibrosis and consequent heart failure via FoxO3a-induced fibroblast activation and differentiation into collagen-producing myofibroblasts.